Chapter 1. Research Scope

1.1. Research Objectives

1.2. Market Definition

1.3. Analysis Period

1.4. Market Size Breakdown by Segments

1.4.1. Market size breakdown, by product

1.4.2. Market size breakdown, by class

1.4.3. Market size breakdown, by application

1.4.4. Market size breakdown, by end user

1.4.5. Market size breakdown, by region

1.4.6. Market size breakdown, by country

1.5. Market Data Reporting Unit

1.5.1. Value

1.6. Key Stakeholders

Chapter 2. Research Methodology

2.1. Secondary Research

2.1.1. Paid

2.1.2. Unpaid

2.1.3. P&S Intelligence database

2.2. Primary Research

2.3. Market Size Estimation

2.4. Data Triangulation

2.5. Currency Conversion Rates

2.6. Assumptions for the Study

2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Market Indicators

Chapter 5. Industry Outlook

5.1. Market Dynamics

5.1.1. Trends

5.1.2. Drivers

5.1.3. Restraints/challenges

5.1.4. Impact analysis of drivers/restraints

5.2. Impact of COVID-19

5.3. Porter’s Five Forces Analysis

5.3.1. Bargaining power of buyers

5.3.2. Bargaining power of suppliers

5.3.3. Threat of new entrants

5.3.4. Intensity of rivalry

5.3.5. Threat of substitutes

Chapter 6. Global Market

6.1. Overview

6.2. Market Revenue, by Product (2017–2030)

6.3. Market Revenue, by Class (2017–2030)

6.3.1. Class I market revenue, by type (2017–2030)

6.3.2. Class II market revenue, by type (2017–2030)

6.3.3. Class III market revenue, by type (2017–2030)

6.4. Market Revenue, by Application (2017–2030)

6.5. Market Revenue, by End User (2017–2030)

6.6. Market Revenue, by Region (2017–2030)

Chapter 7. North America Market

7.1. Overview

7.2. Market Revenue, by Product (2017–2030)

7.3. Market Revenue, by Class (2017–2030)

7.3.1. Class I market revenue, by type (2017–2030)

7.3.2. Class II market revenue, by type (2017–2030)

7.3.3. Class III market revenue, by type (2017–2030)

7.4. Market Revenue, by Application (2017–2030)

7.5. Market Revenue, by End User (2017–2030)

7.6. Market Revenue, by Country (2017–2030)

Chapter 8. Europe Market

8.1. Overview

8.2. Market Revenue, by Product (2017–2030)

8.3. Market Revenue, by Class (2017–2030)

8.3.1. Class I market revenue, by type (2017–2030)

8.3.2. Class II market revenue, by type (2017–2030)

8.3.3. Class III market revenue, by type (2017–2030)

8.4. Market Revenue, by Application (2017–2030)

8.5. Market Revenue, by End User (2017–2030)

8.6. Market Revenue, by Country (2017–2030)

Chapter 9. APAC Market

9.1. Overview

9.2. Market Revenue, by Product (2017–2030)

9.3. Market Revenue, by Class (2017–2030)

9.3.1. Class I market revenue, by type (2017–2030)

9.3.2. Class II market revenue, by type (2017–2030)

9.3.3. Class III market revenue, by type (2017–2030)

9.4. Market Revenue, by Application (2017–2030)

9.5. Market Revenue, by End User (2017–2030)

9.6. Market Revenue, by Country (2017–2030)

Chapter 10. LATAM Market

10.1. Overview

10.2. Market Revenue, by Product (2017–2030)

10.3. Market Revenue, by Class (2017–2030)

10.3.1. Class I market revenue, by type (2017–2030)

10.3.2. Class II market revenue, by type (2017–2030)

10.3.3. Class III market revenue, by type (2017–2030)

10.4. Market Revenue, by Application (2017–2030)

10.5. Market Revenue, by End User (2017–2030)

10.6. Market Revenue, by Country (2017–2030)

Chapter 11. MEA Market

11.1. Overview

11.2. Market Revenue, by Product (2017–2030)

11.3. Market Revenue, by Class (2017–2030)

11.3.1. Class I market revenue, by type (2017–2030)

11.3.2. Class II market revenue, by type (2017–2030)

11.3.3. Class III market revenue, by type (2017–2030)

11.4. Market Revenue, by Application (2017–2030)

11.5. Market Revenue, by End User (2017–2030)

11.6. Market Revenue, by Country (2017–2030)

Chapter 12. U.S. Market

12.1. Overview

12.2. Market Revenue, by Product (2017–2030)

12.3. Market Revenue, by Class (2017–2030)

12.3.1. Class I market revenue, by type (2017–2030)

12.3.2. Class II market revenue, by type (2017–2030)

12.3.3. Class III market revenue, by type (2017–2030)

12.4. Market Revenue, by Application (2017–2030)

12.5. Market Revenue, by End User (2017–2030)

Chapter 13. Canada Market

13.1. Overview

13.2. Market Revenue, by Product (2017–2030)

13.3. Market Revenue, by Class (2017–2030)

13.3.1. Class I market revenue, by type (2017–2030)

13.3.2. Class II market revenue, by type (2017–2030)

13.3.3. Class III market revenue, by type (2017–2030)

13.4. Market Revenue, by Application (2017–2030)

13.5. Market Revenue, by End User (2017–2030)

Chapter 14. Germany Market

14.1. Overview

14.2. Market Revenue, by Product (2017–2030)

14.3. Market Revenue, by Class (2017–2030)

14.3.1. Class I market revenue, by type (2017–2030)

14.3.2. Class II market revenue, by type (2017–2030)

14.3.3. Class III market revenue, by type (2017–2030)

14.4. Market Revenue, by Application (2017–2030)

14.5. Market Revenue, by End User (2017–2030)

Chapter 15. France Market

15.1. Overview

15.2. Market Revenue, by Product (2017–2030)

15.3. Market Revenue, by Class (2017–2030)

15.3.1. Class I market revenue, by type (2017–2030)

15.3.2. Class II market revenue, by type (2017–2030)

15.3.3. Class III market revenue, by type (2017–2030)

15.4. Market Revenue, by Application (2017–2030)

15.5. Market Revenue, by End User (2017–2030)

Chapter 16. U.K. Market

16.1. Overview

16.2. Market Revenue, by Product (2017–2030)

16.3. Market Revenue, by Class (2017–2030)

16.3.1. Class I market revenue, by type (2017–2030)

16.3.2. Class II market revenue, by type (2017–2030)

16.3.3. Class III market revenue, by type (2017–2030)

16.4. Market Revenue, by Application (2017–2030)

16.5. Market Revenue, by End User (2017–2030)

Chapter 17. Italy Market

17.1. Overview

17.2. Market Revenue, by Product (2017–2030)

17.3. Market Revenue, by Class (2017–2030)

17.3.1. Class I market revenue, by type (2017–2030)

17.3.2. Class II market revenue, by type (2017–2030)

17.3.3. Class III market revenue, by type (2017–2030)

17.4. Market Revenue, by Application (2017–2030)

17.5. Market Revenue, by End User (2017–2030)

Chapter 18. Spain Market

18.1. Overview

18.2. Market Revenue, by Product (2017–2030)

18.3. Market Revenue, by Class (2017–2030)

18.3.1. Class I market revenue, by type (2017–2030)

18.3.2. Class II market revenue, by type (2017–2030)

18.3.3. Class III market revenue, by type (2017–2030)

18.4. Market Revenue, by Application (2017–2030)

18.5. Market Revenue, by End User (2017–2030)

Chapter 19. Japan Market

19.1. Overview

19.2. Market Revenue, by Product (2017–2030)

19.3. Market Revenue, by Class (2017–2030)

19.3.1. Class I market revenue, by type (2017–2030)

19.3.2. Class II market revenue, by type (2017–2030)

19.3.3. Class III market revenue, by type (2017–2030)

19.4. Market Revenue, by Application (2017–2030)

19.5. Market Revenue, by End User (2017–2030)

Chapter 20. China Market

20.1. Overview

20.2. Market Revenue, by Product (2017–2030)

20.3. Market Revenue, by Class (2017–2030)

20.3.1. Class I market revenue, by type (2017–2030)

20.3.2. Class II market revenue, by type (2017–2030)

20.3.3. Class III market revenue, by type (2017–2030)

20.4. Market Revenue, by Application (2017–2030)

20.5. Market Revenue, by End User (2017–2030)

Chapter 21. India Market

21.1. Overview

21.2. Market Revenue, by Product (2017–2030)

21.3. Market Revenue, by Class (2017–2030)

21.3.1. Class I market revenue, by type (2017–2030)

21.3.2. Class II market revenue, by type (2017–2030)

21.3.3. Class III market revenue, by type (2017–2030)

21.4. Market Revenue, by Application (2017–2030)

21.5. Market Revenue, by End User (2017–2030)

Chapter 22. Australia Market

22.1. Overview

22.2. Market Revenue, by Product (2017–2030)

22.3. Market Revenue, by Class (2017–2030)

22.3.1. Class I market revenue, by type (2017–2030)

22.3.2. Class II market revenue, by type (2017–2030)

22.3.3. Class III market revenue, by type (2017–2030)

22.4. Market Revenue, by Application (2017–2030)

22.5. Market Revenue, by End User (2017–2030)

Chapter 23. South Korea Market

23.1. Overview

23.2. Market Revenue, by Product (2017–2030)

23.3. Market Revenue, by Class (2017–2030)

23.3.1. Class I market revenue, by type (2017–2030)

23.3.2. Class II market revenue, by type (2017–2030)

23.3.3. Class III market revenue, by type (2017–2030)

23.4. Market Revenue, by Application (2017–2030)

23.5. Market Revenue, by End User (2017–2030)

Chapter 24. Brazil Market

24.1. Overview

24.2. Market Revenue, by Product (2017–2030)

24.3. Market Revenue, by Class (2017–2030)

24.3.1. Class I market revenue, by type (2017–2030)

24.3.2. Class II market revenue, by type (2017–2030)

24.3.3. Class III market revenue, by type (2017–2030)

24.4. Market Revenue, by Application (2017–2030)

24.5. Market Revenue, by End User (2017–2030)

Chapter 25. Mexico Market

25.1. Overview

25.2. Market Revenue, by Product (2017–2030)

25.3. Market Revenue, by Class (2017–2030)

25.3.1. Class I market revenue, by type (2017–2030)

25.3.2. Class II market revenue, by type (2017–2030)

25.3.3. Class III market revenue, by type (2017–2030)

25.4. Market Revenue, by Application (2017–2030)

25.5. Market Revenue, by End User (2017–2030)

Chapter 26. Saudi Arabia Market

26.1. Overview

26.2. Market Revenue, by Product (2017–2030)

26.3. Market Revenue, by Class (2017–2030)

26.3.1. Class I market revenue, by type (2017–2030)

26.3.2. Class II market revenue, by type (2017–2030)

26.3.3. Class III market revenue, by type (2017–2030)

26.4. Market Revenue, by Application (2017–2030)

26.5. Market Revenue, by End User (2017–2030)

Chapter 27. South Africa Market

27.1. Overview

27.2. Market Revenue, by Product (2017–2030)

27.3. Market Revenue, by Class (2017–2030)

27.3.1. Class I market revenue, by type (2017–2030)

27.3.2. Class II market revenue, by type (2017–2030)

27.3.3. Class III market revenue, by type (2017–2030)

27.4. Market Revenue, by Application (2017–2030)

27.5. Market Revenue, by End User (2017–2030)

Chapter 28. U.A.E. Market

28.1. Overview

28.2. Market Revenue, by Product (2017–2030)

28.3. Market Revenue, by Class (2017–2030)

28.3.1. Class I market revenue, by type (2017–2030)

28.3.2. Class II market revenue, by type (2017–2030)

28.3.3. Class III market revenue, by type (2017–2030)

28.4. Market Revenue, by Application (2017–2030)

28.5. Market Revenue, by End User (2017–2030)

Chapter 29. Competitive Landscape

29.1. List of Market Players and their Offerings

29.2. Competitive Benchmarking of Key Players

29.3. Product Benchmarking of Key Players

29.4. Recent Strategic Developments

Chapter 30. Company Profiles

30.1. Acelity L.P. Inc.

30.1.1. Business overview

30.1.2. Product and service offerings

30.1.3. Key financial summary

30.2. MiMedx Group Inc.

30.2.1. Business overview

30.2.2. Product and service offerings

30.2.3. Key financial summary

30.3. Organogenesis Inc.

30.3.1. Business overview

30.3.2. Product and service offerings

30.3.3. Key financial summary

30.4. Vericel Corporation

30.4.1. Business overview

30.4.2. Product and service offerings

30.4.3. Key financial summary

30.5. FUJIFILM Cellular Dynamics Inc.

30.5.1. Business overview

30.5.2. Product and service offerings

30.5.3. Key financial summary

30.6. Smith & Nephew plc

30.6.1. Business overview

30.6.2. Product and service offerings

30.6.3. Key financial summary

30.7. Integra LifeSciences Holdings Corporation

30.7.1. Business overview

30.7.2. Product and service offerings

30.7.3. Key financial summary

30.8. AlloSource

30.8.1. Business overview

30.8.2. Product and service offerings

30.8.3. Key financial summary

30.9. MatTek Corporation

30.9.1. Business overview

30.9.2. Product and service offerings

30.9.3. Key financial summary

Chapter 31. Appendix

31.1. Abbreviations

31.2. Sources and References

31.3. Related Reports

※参考情報 皮膚代替品や代用品は、医療や研究分野で重要な役割を果たしています。これらは、皮膚の再生や修復を支援するために設計されており、さまざまな種類と用途があります。具体的には、創傷治療、皮膚疾患の治療、美容目的などで使用されることが多いです。 皮膚代替品は、人工的に設計された材料で構成されていることが一般的です。これには、生体材料や合成ポリマーが含まれます。生体材料は、天然の材料を使用しており、例えば、コラーゲンやエラスチンなどが利用されることが多いです。これらの天然成分は、体内に馴染みやすく、拒絶反応が起こりにくいため、創傷治療や再生医療に適しています。 一方、合成ポリマーは、人工的に作られた材料であり、長期間のストレージが可能であり、コストが抑えられる場合があるため、広く利用されています。これには、ポリ乳酸やポリビニルアルコールなどがあり、特定の用途に応じて加工されます。 皮膚代替品には、主に再生した皮膚を提供するスキンガッシーや、創傷を保護しながら、新しい皮膚の形成を促すエンハンサーなど、さまざまなタイプがあります。スキンガッシーは、主に外科手術や大きな創傷の治療に使用され、皮膚の機能を補完する役割を果たします。エンハンサーは、主に軽度の創傷や擦り傷の治療に使用され、新しい皮膚の再生を助けるための環境を提供します。 用途に関しては、皮膚代替品は特に外科的手術後の回復や、火傷、褥瘡、糖尿病性創傷などの治療に用いられます。創傷治療では、細菌感染のリスクを低下させ、痛みを軽減する効果があります。また、美容業界でも用いられ、皮膚の若返りやしわの改善を目的とした治療に利用されます。これにより、患者は安定した施術の選択肢を持つことができるようになります。 関連技術としては、3Dプリンティングやバイオプリンティングが挙げられます。これらの技術は、患者の皮膚の形状や構造を再現したカスタムメイドの皮膚代替品の製作を可能にします。3Dプリンティングは、さまざまな材料を層状に積み重ねることで立体的な構造物を作成する方法です。バイオプリンティングに関しては、生細胞を用いてリアルな組織や器官を構築する技術で、将来的には移植用の皮膚が作成できるようになる可能性があります。 また、皮膚代替品の開発には、細胞生物学や材料科学、ナノテクノロジーなどの学際的な知識が求められます。これにより、皮膚再生を促進するための最適なマトリックスや、生体適合性の高い材料が研究されています。新しい技術が進化することで、より効果的で安全な皮膚代替品が市場に登場することが期待されています。 このように、皮膚代替品や代用品は、医療や美容分野において非常に多様な用途を持ち、関連技術の進展とともにその可能性は広がっています。今後の研究開発によって、より自然な仕上がりや機能を持つ製品が登場し、多くの人々の生活の質を向上させることが期待されます。皮膚代替品は、持続可能な医療の選択肢としても重要であり、これからの進展が楽しみです。